T-cell receptor–CD3 complex (TCR–CD3 complex) (TCR–CD3)

The T-cell receptor–CD3 (TCR–CD3) complex is a multi-subunit transmembrane protein assembly found on the surface of T lymphocytes, essential for the adaptive immune response (UniProt P07766). It consists of an antigen-binding TCR alpha/beta or gamma/delta heterodimer non-covalently associated with four invariant CD3 signaling chains: epsilon (ε), delta (δ), gamma (γ), and zeta (ζ) (Wikipedia). The CD3 epsilon subunit is a critical component that forms heterodimers with CD3 delta or gamma and contains immunoreceptor tyrosine-based activation motifs (ITAMs) that transduce signals into the cytoplasm upon antigen recognition, leading to T-cell activation and proliferation (NCBI Gene ID 916). In clinical medicine, the TCR–CD3 complex, particularly the CD3 epsilon chain, is a major therapeutic target for monoclonal antibodies and bispecific T-cell engagers (BiTEs). These therapies are used to treat hematologic malignancies by redirecting T-cell cytotoxicity against tumor cells (PubMed PMID: 30635454) or to manage autoimmune diseases and transplant rejection by inducing immunosuppression through T-cell depletion or TCR downregulation (PubMed PMID: 31412177). However, the potent activation of T cells by these agents can lead to significant safety concerns, most notably cytokine release syndrome (CRS) and neurotoxicity (ICANS), which require intensive clinical monitoring (StatPearls).

Other names

CD3 epsilonCD3ET3ETCRET-cell surface glycoprotein CD3 epsilon chainT-cell surface antigen T3/Leu-4 epsilon chainCD3 complexT-cell receptor complex

Redirected T-cell cytotoxicity via bispecific engagement, T-cell depletion, T-cell activation (agonism), and TCR downregulation/internalization (immunosuppression).